Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marco Ranzani

3PUBLICATIONS
72CO-AUTHORS
Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.

|Feb 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang

|Jan 23, 2023
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Gonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo

Pageof 1

Frequent Collaborators

3 joint publications

Graeme C M Smith

3 joint publications

Helen M R Robinson

3 joint publications

Eeson Rajendra

3 joint publications

Marie Laure Boursier

3 joint publications

Jayesh Majithiya

2 joint publications

Gonzalo Rodriguez-Berriguete

2 joint publications

Nicole Machado

2 joint publications

Robert A Heald

2 joint publications

Alessandro Cicconi

2 joint publications

Vera Grinkevich

Frequent Collaborators

3 joint publications

Graeme C M Smith

3 joint publications

Helen M R Robinson

3 joint publications

Eeson Rajendra

3 joint publications

Marie Laure Boursier